Carotid Endarterectomy: Surgical Treatment for Symptomatic Carotid Artery Disease
-
May 27, 2026
May 27, 2026
What starts at UCI Health can help shape the national conversation.
June 30, 2026
The phase 3 LITESPARK-022 trial compared adjuvant pembrolizumab plus belzutifan with pembrolizumab plus placebo following resection of clear-cell renal-cell carcinoma.
July 8, 2026
Efforts to align, sustain, and engage drove a year of growth for ASE.
June 26, 2026